investor conferences

Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotech firm advancing innovative therapies for autoimmune and inflammatory diseases, has announced that its management team will engage with investors at two major conferences in Miami next week. The schedule includes a fireside chat at the Leerink Global Healthcare Conference on March 10, 2026, followed by one-on-one meetings … Read more